F. Barry Bays, Director at TREACE MEDICAL CONCEPTS, INC. (TMCI), sold 27,120 shares at $24.07 ($646K) on 2023-03-13, disclosed to the SEC on 2023-03-15.
Open-market sale of $646k TMCI by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $24.07 | 8,320 | $200K | 31.0% |
| 2 | $24.07 | 8,320 | $200K | 31.0% |
| 3 | $24.73 | 1,080 | $27K | 4.1% |
| 4 | $23.25 | 9,400 | $219K | 33.8% |
| Total | $23.81 avg | 27,120 | $646K | 100% |
| Filing → |
| TMCI | SELL | 2023-04-13 | $4.5M | — | Filing → |
| TMCI | SELL | 2023-03-30 | $3.0M | — | Filing → |
| TMCI | SELL | 2023-02-23 | $615K | — | Filing → |